Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 13;155(9):409-410.
doi: 10.1016/j.medcli.2020.05.041. Epub 2020 Jul 28.

Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease

[Article in English, Spanish]
Roberto Lozano  1 , María-Esther Franco  2
Affiliations

Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease

[Article in English, Spanish]
Roberto Lozano et al. Med Clin (Barc). .
No abstract available

PubMed Disclaimer

References

    1. Llitjos J.-F., Leclerc M., Chochois C., Monsallier J.M., Ramakers M., Auvray M. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18:1743–1746. doi: 10.1111/jth.14869. - DOI - PMC - PubMed
    1. Warkentin T.E., Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:311–337. - PubMed
    1. Xuan L, Xiaopeng Z, Yongjiu X, Ting G, Guangfei W, Zhongyi W, et-al. Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment. medRxiv. 10.1101/2020.04.23.20076851
    1. Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. doi: 10.1111/jth.14817. - DOI - PMC - PubMed

MeSH terms